Some evidence shows a relationship between gastrointestinal stromal tumor and RCC, where genes coding for tyrosine kinase receptors such as c-MET and c-KIT might be involved, establishing the consideration of using tyrosine kinase inhibitors with the same target to treat them, but no other mechanisms have been proposed to date. Here, KIT is linked to renal cell carcinoma.